Diltiazem for use in the treatment of microbial infections
US12285433B2 · kind B2 · utility
0Cited by
3References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 23, 2019 |
| Grant date | Apr 29, 2025 |
| Priority date | — |
| Expiry date | May 17, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to diltiazem for use as an agent for activating the expression of at least one gene encoding a type III interferon, in the prevention and/or treatment of infections by at least one pathogenic microorganism of the epithelia of the respiratory and/or intestinal tracts.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.